GLP-1 Patches vs GLP-1 Injections: Why One Is a Drug and the Other Is a Supplement

The comparison below is the whole article in one place. On regulatory status. The injections are FDA-approved drugs with approved indications, prescribing information, contraindications and post-marketing surveillance. The patch is a dietary supplement, which in the US means it reaches market without pre-approval and carries the standard disclaimer that its claims have not been evaluated by the FDA. On what is inside. The injections contain semaglutide or tirzepatide — synthetic peptides that bind and activate the GLP-1 receptor (and, for tirzepatide, the GIP receptor as well). The patch contains plant extracts whose proposed mechanism is influencing your own endogenous GLP-1 secretion. On evidence. The injections have large, randomised, placebo-controlled trials with published weight loss outcomes and, for some, cardiovascular outcome data. The patch has testimonials. On what the FTC says. This is the most concrete point available. The FTC's published guide "Gut Check: A Reference Guide for Media on Spotting False Weight Loss Claims" lists seven claims that "experts say simply can't be true", explicitly covering "patches, creams, wraps, and similar products worn on the body or rubbed into the skin." One of the seven is "causes substantial weight loss by wearing a product on the body or rubbing it into the skin." The guide also states that "substantial weight loss can be suggested by reference to dress size, inches, or body fat", and that "it's not enough to say 'results not typical'."

Injection is not a marketing choice or a way of gatekeeping. It is forced by chemistry, and understanding why explains why no patch version exists. GLP-1 receptor agonists are peptides — chains of amino acids. Semaglutide has a molecular weight of roughly 4,100 daltons. Tirzepatide is larger still. That creates two insurmountable problems for any other route. Digestion destroys peptides. Swallow a peptide and your gut treats it as food — proteases break it into fragments. This is why the one oral semaglutide product on the market required a specialised absorption enhancer to work at all, and even then achieves very low bioavailability. It is a genuine pharmaceutical achievement and it took years of development. Skin blocks large molecules. The stratum corneum admits small, lipophilic, uncharged molecules. The practical working limit is around 500 daltons. At roughly 4,100 daltons, semaglutide is about eight times that ceiling — and it is a charged, water-soluble peptide besides. There is no formulation trick that puts a peptide of that size through intact skin at a therapeutic dose. So: if a product claims to deliver a GLP-1 receptor agonist through a patch, that claim is not achievable. And if a product called a GLP-1 patch does not claim to contain the drug — which is the case here — then it is a botanical supplement borrowing a pharmaceutical name. The same reasoning disposes of the botanical dose question. Berberine's human metabolic evidence comes from oral doses of roughly 1,000 to 1,500 mg per day. Every successful transdermal drug is potent at micrograms to a few milligrams daily — nicotine, fentanyl, estradiol, scopolamine. You cannot deliver a gram-scale dose through a patch. The gap is orders of magnitude, and it is not a formulation problem anyone is close to solving. The transferable test: for any patch product, look up the studied oral dose of the active ingredient. If it is hundreds of milligrams or more, the patch cannot reproduce it.

The price comparison has changed significantly and most people have not caught up. The patch. $52.10 for a single bag; $312.39 for nine bags (270 patches), advertised as 70% off a $449.90 bundle value. At the bundle rate that is roughly $35 per month. Note the guarantee is 30 days against a 270-day supply. The approved drugs, self-pay. Manufacturer-direct programmes now exist — LillyDirect for Zepbound and NovoCare Pharmacy for Wegovy — with published self-pay pricing that has fallen substantially over the past two years. Check the current figures directly, because they have moved repeatedly. With insurance, the picture can be dramatically better. Coverage varies enormously by plan, and many people assume they are not covered without checking. A prior authorisation is often required and often granted. Check before assuming. Compounded versions, sold by telehealth services, sit between the two. They are not FDA-approved, are not generics, and have not been shown to be therapeutically equivalent — and the price gap that once justified them has narrowed considerably now that manufacturer self-pay pricing exists. The honest sequence for someone deciding: Check your insurance first. It is free and it is the biggest possible saving. Check manufacturer-direct self-pay pricing for the approved products. Then, if neither works, consider compounded telehealth — with the caveats above, and asking whether the price rises as your dose escalates. The patch is not a step on this ladder. It is a different product category and it does not substitute for any rung. And be honest about the ongoing nature of the cost. Weight regain after stopping GLP-1 treatment is the norm in the published follow-up data. Whatever route you choose, budget as if this is long-term.

For people for whom a prescription is not right or not available, here is the honest alternatives list — none of it exciting, all of it better supported than a patch. Oral berberine, if that is the ingredient you were interested in. It has genuinely interesting human evidence at studied doses for blood glucose and lipids. Take it orally at 500 mg two or three times daily as used in trials — not through skin. Important: berberine interacts with many medications through CYP enzymes and P-glycoprotein, including some statins, immunosuppressants and anticoagulants. It should not be used in pregnancy or in infants. Tell your prescriber. Protein and fibre. The two dietary levers with the most reliable effect on satiety. This is the mechanism the patches gesture at, and food does it better. Resistance training. Preserves lean mass during weight loss, which is the component most people skip and the one that most affects how you look and function at the end. Sleep. Short sleep measurably disrupts appetite regulation. It is free and most people are not doing it. A calorie deficit you can actually maintain. Adherence beats method. The best diet is the one you will still be following in six months. And get the medical causes excluded. Hypothyroidism, PCOS, sleep apnoea, depression, Cushing's syndrome and several common medications — including some antipsychotics, antidepressants, steroids and beta blockers — all affect weight. Weight that will not move despite genuine sustained effort is a reason to see a doctor, and that appointment is more likely to change the outcome than anything on a supplement shelf. One thing worth saying plainly: the reason GLP-1 drugs have been transformative is not willpower or discipline. They work on the biology of appetite regulation directly, at doses your own gut does not produce. If that biology is the problem for you, the answer is the drug or nothing that mimics it — and "supporting natural production" is not the same intervention.

Is there a semaglutide patch? No. Semaglutide is roughly 4,100 daltons and the practical ceiling for crossing intact skin is around 500 daltons. There is no formulation that delivers a peptide that size transdermally at a therapeutic dose. What is actually in a GLP-1 patch? Botanical extracts — berberine and green tea extract in the product reviewed here — marketed as supporting your body's own GLP-1 production. Why are GLP-1 drugs injected? Peptides are destroyed by digestion and cannot cross skin. The one oral semaglutide product required a specialised absorption enhancer and still achieves very low bioavailability. Do weight loss patches work? The FTC lists "causes substantial weight loss by wearing a product on the body or rubbing it into the skin" among seven claims that experts say cannot be true, and explicitly includes patches in scope. What does each cost? The patch runs $52.10 to $312.39 per bundle. The approved drugs now have manufacturer-direct self-pay programmes with pricing that has fallen substantially — check LillyDirect and NovoCare directly, and check your insurance first. Are compounded GLP-1s a good middle option? They are not FDA-approved, are not generics, and have not been shown to be therapeutically equivalent. The price gap that justified them has narrowed considerably. Should I take berberine instead? If the ingredient interests you, take it orally at studied doses rather than through a patch — and check interactions with your prescriber, as it affects many medications. Will I keep the weight off after stopping a GLP-1? Regain after stopping is the norm in published follow-up data. Budget as if this is long-term treatment. What if I cannot afford any of it? Protein, fibre, resistance training, sleep and a maintainable deficit have real evidence. And get medical causes excluded — several are common and treatable. Is "supporting natural GLP-1 production" the same thing? No. The drugs work by delivering sustained receptor activation at doses your own gut never produces.